📰 Breaking News: Lessons Learnt & Insights from DSTBTD Restructuring Plan

Notices to creditors (MVL)

Verso Biosense R&D Limited

active Company no. 09890252 Published 28 September 2026

In short: Verso Biosense R&D Limited (company no. 09890252) entered members' voluntary liquidation, a solvent and planned closure, according to a Notices to creditors (MVL) notice published in The London Gazette on 28 September 2026. The office holders are Nicola Kate Clark (IP No. 19390) of MHA Advisory Limited, 80 Mosley Street, Manchester, M2 3FX; Andrew John Duncan (IP No. 9319) of MHA Advisory Limited, 6th Fl.

The notice informs creditors of VERSO BIOSENSE R&D LIMITED that a final distribution will be made after its voluntary winding up and sets a deadline to submit claims.

Notice details

Company
VERSO BIOSENSE R&D LIMITED
Company number
09890252
Registered office
MHA Advisory Ltd, 6th Floor, 2 London Wall Place, London, EC2Y 5AU (Formerly) 115b Innovation Drive, Milton Park, Milton, Abingdon, Oxfordshire, OX14 4RZ
Principal trading address
N/A
Liquidator(s)
Nicola Kate Clark (IP No. 19390) of MHA Advisory Limited, 80 Mosley Street, Manchester, M2 3FX; Andrew John Duncan (IP No. 9319) of MHA Advisory Limited, 6th Floor, 2 London Wall Place, London, EC2Y 5AU
Type of liquidation
Voluntary liquidation (MVL)
Winding‑up date
23 September 2026
Claim submission deadline
26 October 2026
Contact
Fahad Mohammed, Email: [email protected], Tel: 020 8146 2375
Publication date
28 September 2026

What this notice means

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Read more: What is Liquidation?.

All notices for Verso Biosense R&D Limited

3 Gazette notices on record for company no. 09890252, newest first. The full history, with last filed accounts, is on the Verso Biosense R&D Limited company record.

  1. Appointment of liquidators (MVL) 28 Sep 2026
  2. Resolution for winding up (MVL) 28 Sep 2026

How does this notice affect you?

Choose what applies and we'll point you at the right next step.

Would rather just talk? 020 7720 8000

Related guidance

Free, practical guides from K2 on what this kind of notice means for directors.

More liquidation notices

← Back to all notices

Frequently asked questions

Is Verso Biosense R&D Limited in financial difficulty?

No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Notices to creditors (MVL) for Verso Biosense R&D Limited (company no. 09890252) on 28 September 2026.

What does a Notices to creditors (MVL) mean?

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Who is dealing with the liquidation?

The office holders named in the notice: Nicola Kate Clark (IP No. 19390) of MHA Advisory Limited, 80 Mosley Street, Manchester, M2 3FX; Andrew John Duncan (IP No. 9319) of MHA Advisory Limited, 6th Fl. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.

Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.